Literature DB >> 8465793

Demographic features and prevalence of idiopathic myocarditis in patients undergoing endomyocardial biopsy.

A Herskowitz1, S Campbell, J Deckers, E K Kasper, J Boehmer, D Hadian, D A Neumann, K L Baughman.   

Abstract

From January 1985 through December 1990, 534 patients underwent endomyocardial biopsy at Johns Hopkins Hospital for suspected myocarditis. One hundred thirty-eight (26%) biopsy specimens were diagnosed histologically by 2 cardiac pathologists as either active (n = 85, 16%) or borderline (n = 53, 10%) myocarditis. Of the 138 patients, 60 were excluded based on either specific concurrent clinical conditions or noncongestive heart failure presentations. Immunohistochemical staining for common leukocyte antigen infiltrating cells performed on the remaining 78 specimens confirmed the presence of focal or multifocal inflammatory infiltrates in 58, of which 49 had histologic evidence of active myocarditis. All 49 patients presented with congestive heart failure and left ventricular ejection fractions of < 40%. Compared with patients with either idiopathic dilated cardiomyopathy (n = 207) or ischemic cardiomyopathy (n = 44), these patients with myocarditis had a less striking male predominance (58 vs 69 and 83%, respectively) (p = 0.02) and were younger (43 +/- 16 vs 50 +/- 17 and 55 +/- 13 years, respectively, p = 0.005). Racial distributions were similar. A recent history of a discrete flu-like illness was obtained in 52%, two-thirds of which were clustered between the months of December and March. Onset of heart failure peaked between December and April (63% and was low between May through September (22%). A peak in the proportion of patients found to have active myocarditis on biopsy occurred in 1986 (17 vs 7 to 10% in other years).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1993        PMID: 8465793     DOI: 10.1016/0002-9149(93)90918-3

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  14 in total

Review 1.  Influence of myocarditis on left ventricular function.

Authors:  K L Baughman
Journal:  Trans Am Clin Climatol Assoc       Date:  2000

Review 2.  Scintigraphic detection of inflammatory heart disease.

Authors:  A J Morguet; D L Munz; H Kreuzer; D Emrich
Journal:  Eur J Nucl Med       Date:  1994-07

Review 3.  Viral myocarditis--diagnosis, treatment options, and current controversies.

Authors:  Ari Pollack; Amy R Kontorovich; Valentin Fuster; G William Dec
Journal:  Nat Rev Cardiol       Date:  2015-07-21       Impact factor: 32.419

4.  Spontaneous autoimmune myocarditis and cardiomyopathy in HLA-DQ8.NODAbo transgenic mice.

Authors:  Veena Taneja; Chella S David
Journal:  J Autoimmun       Date:  2009-10-07       Impact factor: 7.094

Review 5.  Cardiovascular Involvement in COVID-19: What Sequelae Should We Expect?

Authors:  Maria Vincenza Polito; Angelo Silverio; Michele Bellino; Giuseppe Iuliano; Marco Di Maio; Carmine Alfano; Patrizia Iannece; Nicolino Esposito; Gennaro Galasso
Journal:  Cardiol Ther       Date:  2021-06-30

Review 6.  Contrast-enhanced cardiac MR imaging.

Authors:  G Schneider; P Fries; F Ahlhelm; I Kindermann; B Kramann; M Böhm
Journal:  Eur Radiol       Date:  2003-11       Impact factor: 7.034

7.  Acute viral hepatitis e is associated with the development of myocarditis.

Authors:  M Premkumar; Devraja Rangegowda; Chitranshu Vashishtha; Vikram Bhatia; Jelen Singh Khumuckham; Badal Kumar
Journal:  Case Reports Hepatol       Date:  2015-01-31

8.  Third-Degree Atrioventricular Block and Collapse Associated with Eosinophilic Myocarditis in a Horse.

Authors:  D Luethy; J Slack; M S Kraus; A R Gelzer; P Habecker; A L Johnson
Journal:  J Vet Intern Med       Date:  2017-03-14       Impact factor: 3.333

9.  Eosinophil-derived IL-4 drives progression of myocarditis to inflammatory dilated cardiomyopathy.

Authors:  Nicola L Diny; G Christian Baldeviano; Monica V Talor; Jobert G Barin; SuFey Ong; Djahida Bedja; Allison G Hays; Nisha A Gilotra; Isabelle Coppens; Noel R Rose; Daniela Čiháková
Journal:  J Exp Med       Date:  2017-03-16       Impact factor: 14.307

10.  Cardiac fibroblasts mediate IL-17A-driven inflammatory dilated cardiomyopathy.

Authors:  Lei Wu; SuFey Ong; Monica V Talor; Jobert G Barin; G Christian Baldeviano; David A Kass; Djahida Bedja; Hao Zhang; Asfandyar Sheikh; Joseph B Margolick; Yoichiro Iwakura; Noel R Rose; Daniela Ciháková
Journal:  J Exp Med       Date:  2014-06-16       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.